DE69933549D1 - Pharmakophore rekombination zur identifizierung von "lead"-verbindungen von kleinmolekül-medikamenten - Google Patents

Pharmakophore rekombination zur identifizierung von "lead"-verbindungen von kleinmolekül-medikamenten

Info

Publication number
DE69933549D1
DE69933549D1 DE69933549T DE69933549T DE69933549D1 DE 69933549 D1 DE69933549 D1 DE 69933549D1 DE 69933549 T DE69933549 T DE 69933549T DE 69933549 T DE69933549 T DE 69933549T DE 69933549 D1 DE69933549 D1 DE 69933549D1
Authority
DE
Germany
Prior art keywords
identification
compounds
lead
small molecule
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69933549T
Other languages
English (en)
Other versions
DE69933549T2 (de
Inventor
A Ellman
Ingrid Choong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of DE69933549D1 publication Critical patent/DE69933549D1/de
Application granted granted Critical
Publication of DE69933549T2 publication Critical patent/DE69933549T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69933549T 1998-03-27 1999-03-26 Pharmakophore rekombination zur identifizierung von "lead"-verbindungen von kleinmolekül-medikamenten Expired - Lifetime DE69933549T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49754 1998-03-27
US09/049,754 US6344330B1 (en) 1998-03-27 1998-03-27 Pharmacophore recombination for the identification of small molecule drug lead compounds
PCT/US1999/006734 WO1999049314A1 (en) 1998-03-27 1999-03-26 Pharmacophore recombination for the identification of small molecule drug lead compounds

Publications (2)

Publication Number Publication Date
DE69933549D1 true DE69933549D1 (de) 2006-11-23
DE69933549T2 DE69933549T2 (de) 2007-06-21

Family

ID=21961533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69933549T Expired - Lifetime DE69933549T2 (de) 1998-03-27 1999-03-26 Pharmakophore rekombination zur identifizierung von "lead"-verbindungen von kleinmolekül-medikamenten

Country Status (9)

Country Link
US (5) US6344330B1 (de)
EP (1) EP1066522B1 (de)
JP (1) JP2002507748A (de)
AT (1) ATE342507T1 (de)
AU (1) AU759327B2 (de)
CA (1) CA2326341C (de)
DE (1) DE69933549T2 (de)
IL (1) IL138717A0 (de)
WO (1) WO1999049314A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US20050287596A9 (en) * 1998-06-26 2005-12-29 Braisted Andrew C Novel ligands and libraries of ligands
US6919178B2 (en) 2000-11-21 2005-07-19 Sunesis Pharmaceuticals, Inc. Extended tethering approach for rapid identification of ligands
US20030194745A1 (en) * 1998-06-26 2003-10-16 Mcdowell Robert S. Cysteine mutants and methods for detecting ligand binding to biological molecules
US6998233B2 (en) 1998-06-26 2006-02-14 Sunesis Pharmaceuticals, Inc. Methods for ligand discovery
US6824987B1 (en) * 1999-05-11 2004-11-30 President And Fellows Of Harvard College Small molecule printing
ATE420366T1 (de) * 2000-11-21 2009-01-15 Sunesis Pharmaceuticals Inc ERWEITERTER ßTETHERINGß ANSATZ ZUM SCHNELLEN AUFFINDEN VON LIGANDEN
US20020172967A1 (en) * 2001-02-13 2002-11-21 Gadek Thomas R. Identification of non-covalent complexes by mass spectrometry
US6858148B2 (en) 2003-07-16 2005-02-22 The Regents Of The University Of California Method and apparatus for detecting chemical binding
US9157875B2 (en) * 2001-05-16 2015-10-13 Benjamin P. Warner Drug development and manufacturing
US20040017884A1 (en) * 2002-07-25 2004-01-29 Havrilla George J. Flow method and apparatus for screening chemicals using micro x-ray fluorescence
IL159983A0 (en) * 2001-08-07 2004-06-20 Sunesis Pharmaceuticals Inc Disulfide and thiosulfonate ligands and libraries comprising these ligands
JP4391237B2 (ja) * 2001-11-21 2009-12-24 サネシス ファーマシューティカルズ， インコーポレイテッド リガンド発見のための方法
AU2002321793B8 (en) 2002-07-24 2009-07-09 Keddem Bio-Science Ltd. Drug discovery method
US7519145B2 (en) * 2002-07-25 2009-04-14 Los Alamos National Security, Llc Flow method and apparatus for screening chemicals using micro x-ray fluorescence
AU2003287250B9 (en) * 2002-10-30 2010-01-28 Ptc Therapeutics, Inc. Identifying therapeutic compounds based on their physical-chemical properties
ATE354096T1 (de) 2002-12-23 2007-03-15 Astex Therapeutics Ltd Synthese und screening von liganden mit hilfe von röntgenkristallographie
US7736909B2 (en) * 2003-01-09 2010-06-15 Board Of Regents, The University Of Texas System Methods and compositions comprising capture agents
EP1623216A2 (de) * 2003-04-11 2006-02-08 SGX Pharmaceuticals, Inc. Verbindungsbibliotheken und verfahren zur arzneimittelentdeckung
WO2006124644A2 (en) * 2005-05-12 2006-11-23 Board Of Regents, The University Of Texas System Protein and antibody profiling using small molecule microarrays
JP5174672B2 (ja) * 2005-10-04 2013-04-03 アルケミア リミティッド 薬物設計の方法
CN101384757A (zh) * 2006-01-03 2009-03-11 哈佛大学校长及研究员协会 小分子印渍
DK2084519T3 (da) 2006-10-10 2012-08-20 Los Alamos Nat Security Llc Røntgenfluorescens-analysefremgangsmåde
DE102007023102A1 (de) * 2006-12-19 2008-06-26 Bayer Cropscience Ag Bisoxime als Fungizide
US20090087919A1 (en) 2007-09-28 2009-04-02 Caldera Pharmaceuticals, Inc. Method and Apparatus for Measuring Protein Post-Translational Modification
CA2719579C (en) 2008-03-25 2020-07-21 Sunesis Pharmaceuticals, Inc. Methods of chemotype evolution
KR20120034683A (ko) * 2009-05-29 2012-04-12 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 자가면역 ｔ-세포의 분리 및 처리를 위한 펩토이드 리간드
KR20120122869A (ko) * 2009-06-02 2012-11-07 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 신경변성 질환을 갖는 대상에서 항체에 의해 인식되는 소분자의 확인법
WO2011047257A1 (en) * 2009-10-16 2011-04-21 The Board Of Regents Of The University Of Texas System Compositions and methods for producing cyclic peptoid libraries
EP2588456A1 (de) 2010-07-02 2013-05-08 Syngenta Participations AG Neue mikrobiozide dioximetherderivate
AU2011284714A1 (en) 2010-07-29 2013-01-31 Syngenta Participations Ag Novel microbiocidal dioxime ether derivatives
MX2013011000A (es) 2011-03-24 2014-03-27 Opko Pharmaceuticals Llc Descubrimiento de biomarcador en fluido biologico complejo usando genotecas basadas en microesferao particula y kits de diagnostico y terapeuticos.
CN103930126A (zh) 2011-08-12 2014-07-16 Bsrc亚历山大.弗莱明 Tnf超家族三聚化的抑制剂
WO2013092460A1 (en) 2011-12-20 2013-06-27 Syngenta Participations Ag Cyclic bisoxime microbicides
CN102731450A (zh) * 2012-07-04 2012-10-17 中山大学 一种苯并呋喃或吲哚的制备方法
EP3033625B1 (de) 2013-08-13 2020-01-22 The Scripps Research Institute Nachweis zystein-reaktiver liganden in proteomen
CN104897826B (zh) * 2015-06-16 2016-06-22 广西师范大学 一种用于细胞原位检测小分子化合物与靶蛋白相互作用的方法
EP3334459A4 (de) 2015-08-11 2019-04-17 Arch Biopartners, Inc. Dpep-1-bindungszusammensetzungen und verfahren zur verwendung
US10670605B2 (en) 2015-10-22 2020-06-02 The Scripps Research Institute Cysteine reactive probes and uses thereof
WO2017165438A1 (en) 2016-03-25 2017-09-28 Muralidhar Reddy Moola Combinatorial synthesis and biomarker development
AU2018211066B2 (en) * 2017-01-18 2024-03-21 The Scripps Research Institute Photoreactive ligands and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727022A (en) 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
US5196351A (en) 1987-09-30 1993-03-23 Beckman Instruments, Inc. Bidentate conjugate and method of use thereof
FR2651229B1 (fr) * 1989-08-24 1991-12-13 Inst Nat Sante Rech Med Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique.
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
CA2108147C (en) 1991-04-10 2009-01-06 Angray Kang Heterodimeric receptor libraries using phagemids
WO1993002093A1 (en) * 1991-07-15 1993-02-04 La Jolla Pharmaceutical Company Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
EP0635023B1 (de) 1992-03-05 2002-02-06 Isis Pharmaceuticals, Inc. Kovalent vernetzte oligonukleotide
US5543507A (en) 1992-03-05 1996-08-06 Isis Pharmaceuticals, Inc. Covalently cross-linked oligonucleotides
US5362859A (en) 1992-07-27 1994-11-08 Sepracor, Inc. High-capacity affinity supports and methods for the preparation and use of same
US5512435A (en) 1993-02-05 1996-04-30 Renschler; Markus F. Receptor-binding antiproliferative peptides
JP3615552B2 (ja) * 1995-04-20 2005-02-02 タノックス， インコーポレイテッド 新規なアポトーシス調整タンパク質を用いる治療剤をスクリーニングする方法
DE19521019A1 (de) * 1995-06-13 1996-12-19 Boehringer Mannheim Gmbh Verfahren und Mittel zur gleichzeitigen kolorimetrischen und elektrochemischen Messung eines Analyten
AU711092B2 (en) 1995-11-14 1999-10-07 Abbvie Inc. Use of nuclear magnetic resonance to design ligands to target biomolecules
US5698401A (en) 1995-11-14 1997-12-16 Abbott Laboratories Use of nuclear magnetic resonance to identify ligands to target biomolecules
WO1998011436A1 (en) 1996-09-13 1998-03-19 Whitehead Institute For Biomedical Research Non-specific affinity enhancement to identify combinatorial library members
US6552060B1 (en) * 1997-08-11 2003-04-22 Prolx Pharmaceuticals, Inc. Asymmetric disulfides and methods of using same
US6043024A (en) 1997-04-18 2000-03-28 Abbott Laboratories Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6335155B1 (en) * 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
US7135288B2 (en) * 2002-09-27 2006-11-14 Ut-Battelle, Llc Combinatorial synthesis of ceramic materials

Also Published As

Publication number Publication date
JP2002507748A (ja) 2002-03-12
US6344330B1 (en) 2002-02-05
AU3211399A (en) 1999-10-18
EP1066522B1 (de) 2006-10-11
WO1999049314A1 (en) 1999-09-30
ATE342507T1 (de) 2006-11-15
US20040063157A1 (en) 2004-04-01
US7001727B2 (en) 2006-02-21
US20020115107A1 (en) 2002-08-22
EP1066522A1 (de) 2001-01-10
DE69933549T2 (de) 2007-06-21
CA2326341C (en) 2009-02-17
IL138717A0 (en) 2001-10-31
CA2326341A1 (en) 1999-09-30
WO1999049314A9 (en) 1999-11-18
EP1066522A4 (de) 2005-02-02
US20040132100A1 (en) 2004-07-08
US6344334B1 (en) 2002-02-05
AU759327B2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
DE69933549D1 (de) Pharmakophore rekombination zur identifizierung von "lead"-verbindungen von kleinmolekül-medikamenten
BR9916146A (pt) Produto de revestimento constituìdo de três componentes, processo para sua produção, bem como utilização do mesmo
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
MX218513B (es) Composiciones para revestimiento, curables, con un contenido de mezclas de compuestos carbamato funcionales
BR9807502B1 (pt) compostos orgÂnicos, processo para sua preparaÇço, bem como composiÇço e aplicaÇço dos mesmos.
BRPI0402451A (pt) Compostos colorantes
FR2781667B1 (fr) Patch cosmetique, pharmaceutique, ou dermatologique
NO20000426L (no) Fremgangsmõte for inhibering av biogendannelse av sulfid
DE60044647D1 (de) Sicherheitssystem
MX217065B (es) Composiciones para revestimiento, curables, con contenido de mezclas de compuestos carbamato funcionales
BR9811078A (pt) Composição de revestimento, processo de revestimento de um substrato, e, substrato revistido
FR2774590B1 (fr) Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir bacopa monnieri (l.)
PT868427E (pt) Metodos para identificar compostos que se ligam a um alvo
MX240611B (es) Composiciones curables de recbrimiento, que contienen mezclas de compuestos funcionales de carbamato
DE69611677T2 (de) Pestizide schwefelverbindungen.
BR0007638A (pt) Processo para determinação pós-genÈmica de estruturas atÈmicas macromoleculares
DE69804125T2 (de) Verwendung von immunomodulatoren
GEP19991790B (en) C-2’ Hydroxyl-Bezyl Protected, N-Carbamate Protected (2R,3S)-3-Phenylisoserine and Production Process Therefor
ATE331814T1 (de) Sicherheitssystem
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
DE29713569U1 (de) Trokar zur Einführung von chirurgischen Instrumenten
FR2723313B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant un extrait de centaurium erythraea (= erythraea centaurium)
BR9916243A (pt) Composições de polìmero funcional de carbonato cìclico, e de revestimento de pó curável
NO995187L (no) Hydraulisk bindemiddelsammensetning likesom anvendelsen av denne
ATE257255T1 (de) Verfahren zur absicherung von einsprungsadressen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition